Controlled Substance Testing Program definition

Controlled Substance Testing Program means a program adopted by the SFMTA Board to comply with California Government Code Section 53075.5.
Sample 1Sample 2Sample 3

Examples of Controlled Substance Testing Program in a sentence

  • Post-Accident Testing – If you are in an accident and you are subject to post-accident testing as described in the Alcohol Controlled Substance Testing Program section of this Procedure Manual, you will need to report to the Transportation Office immediately.We will call Midwest/DISA Toxicology Services and they will either send their mobile unit or direct us to an alternate site.

  • Please see the University of Manitoba’s model for Accessibility Advisory Committees.

  • Effective Date:January 1, 2005 3.23 / Commercial Driver's License - Drug and Alcohol Testing‌‌‌ A commercial driver position means any position which is subject to the State of Kansas Alcohol and Controlled Substance Testing Program for Commercial Drivers established under the Federal Omnibus Transportation Employees Testing Act of 1991.

  • Individuals who have any questions about the distributed educational materials or the Testing Program may contact the Union, a Consenting Employer’s DER or CSATF’s Coordinator of the Alcohol and Controlled Substance Testing Program.

  • Participation in the university's CDL Alcohol and Controlled Substance Testing Program is required for these employees and is considered to be a condition of employment.

  • The MTI Alcohol & Controlled Substance Testing Program includes four types of tests: Pre-employment, Random, Post-Accident and Reasonable Suspicion.

  • This policy consists of three interrelated programs: 1) An Employee Education/Supervisor Training Program; 2) An Employee Assistance Program (EAP) and (3) An Alcohol and Controlled Substance Testing Program.

  • Captions and headings throughout this Amendment are for convenience and reference only and the words contained therein shall in no way be held to define or add to the interpretation, construction, or meaning of any provision of this Amendment.

  • The authority for this procedure comes from Federal Motor Carrier Safety Regulations (FMCSR) Part 40 – Procedures for Transportation Workplace Drug and Alcohol Testing Programs, Subparts A – R and from WWCC’s Board Policy, Federal Motor Carrier Safety Administration Mandated Alcohol and Controlled Substance Testing Program.

Related to Controlled Substance Testing Program

  • Controlled substance analog means a substance the chemical structure of which is substantially

  • Controlled substance means a controlled substance in schedules I through V of Section 202 of the Controlled Substances Act (2l U.S.C. 8l2) and as further defined in regulation at 2l CFR l308.ll-l308.l5.

  • Imitation controlled substance means a substance that is

  • Phase I Trial means a clinical trial of a Licensed Product in human patients designated as a Phase I Trial and conducted primarily for the purpose of determining the safety of and/or the metabolism and pharmacologic actions of the Licensed Product in humans, as described under 21 CFR § 312.21(a) (as hereafter modified or amended) and any of its foreign equivalents. For purposes of this definition, Phase I Trial shall specifically exclude trials in healthy volunteers.

  • Cannabis testing facility means an entity registered by

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Penetration Testing means security testing in which assessors mimic real-world attacks to identify methods for circumventing the security features of an application, system, or network. (NIST SP 800-115)

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase I Study means a human clinical trial in any country that would satisfy the requirements of 21 C.F.R. § 312.21(a) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase IV Clinical Trial means a post-registrational Clinical Trial conducted in any country or countries and required as a condition to, or for the maintenance of, any Regulatory Approval for a Product in the Territory.

  • Acceptance Testing mean the tests, reviews and other activities that are performed by or on behalf of Agency to determine whether the Deliverables meet the Acceptance Criteria or otherwise satisfy the Agency, as determined by the Agency in its sole discretion.

  • Phase II Clinical Trial means a study in humans of the safety, dose ranging and efficacy of a product, which is prospectively designed to generate sufficient data (if successful) to commence a Phase III Clinical Trial or to file for accelerated approval, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(b) or its foreign equivalents.

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

  • Alcohol Screening Device (ASD) means a breath or saliva device, other than an Evidential Breath Testing Device (EBT), that is approved by the National Highway Traffic Safety Administration and placed on its Conforming Products List for such devices.

  • Operational Acceptance Tests means the tests specified in the Technical Requirements and Agreed Project Plan to be carried out to ascertain whether the System, or a specified Sub system, is able to attain the functional and performance requirements specified in the Technical Requirements and Agreed Project Plan, in accordance with the provisions of GCC Clause 27.2 (Operational Acceptance Test).

  • Controlled substances means those substances identified in 49 CFR 40.85. “CCF” means the Federal Drug Testing Custody and Control Form.

  • Pivotal Clinical Trial means a Phase 3 Clinical Trial, or a Phase 2b Clinical Trial for which the applicable Regulatory Authority has determined that the data generated in such Phase 2b Clinical Trial would be sufficient, depending on its outcome, to support the Regulatory Approval for the applicable Licensed Product.

  • Substance abuse means alcohol and/or drug abuse, addiction or dependency.

  • Genetic testing means an analysis of genetic markers to exclude or identify a man as the father or a woman as the mother of a child. The term includes an analysis of one or a combination of the following:

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Marijuana testing facility means an entity licensed to analyze and certify the safety and potency of marijuana.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.